CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 108 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03418740
NCT03418740N/ACompleted
CompareCT.gov

Neurological Measures of Progression in Children With Friedrich Ataxia

Children's Hospital of Philadelphia·observational·Posted Feb 1, 2018·Updated Jan 16, 2025

In Brief

An observational study for Friedreich Ataxia. Completed, enrolled 108 participants across 3 sites.

Detailed Summary

The purpose of this study is to identify ways to follow progression of Friedreich's Ataxia (FA) and be able to measure changes over time in children with FA. Participants will have biannual visits to observe how the disease progresses over time and determine the rate of progression. Funding Source- Food and Drug Administration Office of Orphan Products Development (FDA OOPD).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFriedreich Ataxia
CountriesUnited States
CollaboratorsUniversity of Florida, University of California, Los Angeles, Food and Drug Administration (FDA), Friedreich's Ataxia Research Alliance

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 1, 2018
Enrollment StartNov 20, 2017
Primary CompletionFeb 2, 2023
TodayJul 2, 2026
Enrollment to primary: 5.2 yearsPosted 8.4 years ago